[1]
“Meta Analysis: Donepezil in the Treatment of Cognitive Impairment and Dementia in Patients with Parkinson’s Diseas”, Acta Med Philipp, vol. 49, no. 1, Mar. 2015, doi: 10.47895/amp.v49i1.1018.